Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
India and the United Arab Emirates continue to strengthen their defence partnership with the conduct…
Jharkhand has taken a pioneering step in labour reforms with the approval of the Jharkhand…
Rivers in India are full of life and support many kinds of freshwater fish. Some…
Pulitzer Prize winning journalist Peter Arnett, one of the most influential war correspondents of the…
India and Oman have signed a Comprehensive Economic Partnership Agreement (CEPA), marking a major milestone…
China is one of the oldest countries in the world, with a history that goes…